Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its functional groups—bromine, fluorine, and hydroxymethyl—allow for selective cross-coupling reactions, enabling the construction of complex aromatic systems found in drug candidates. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to enhance binding affinity and metabolic stability. Also utilized in the preparation of radiolabeled analogs for use in positron emission tomography (PET) imaging research.